ProfileGDS4718 / 224799_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 96% 72% 96% 96% 92% 93% 96% 97% 97% 95% 96% 98% 97% 94% 95% 96% 95% 91% 81% 96% 95% 97% 96% 95% 95% 94% 91% 95% 95% 94% 89% 95% 97% 96% 96% 93% 95% 96% 65% 97% 96% 87% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.678896
GSM549102patient 115, normal, homogenized [OPG study]10.527496
GSM549104patient 119, normal, homogenized [OPG study]7.1432172
GSM549108patient 138, normal, homogenized [OPG study]10.369796
GSM549119patient 077, normal, homogenized [OPG study]10.567496
GSM549133patient 032, cancer, homogenized [OPG study]9.5988592
GSM549139patient 042, cancer, homogenized [OPG study]9.7727493
GSM549099patient 107, normal, homogenized [OPG study]10.57796
GSM549109patient 139, normal, homogenized [OPG study]10.866397
GSM549110patient 046, normal, homogenized [OPG study]10.96197
GSM549114patient 063, normal, homogenized [OPG study]10.591195
GSM549122patient 082, normal, homogenized [OPG study]10.488996
GSM549134patient 033, cancer, homogenized [OPG study]11.267798
GSM549136patient 036, cancer, homogenized [OPG study]10.739297
GSM549140patient 044, cancer, homogenized [OPG study]9.888294
GSM549111patient 047, normal, homogenized [OPG study]10.324995
GSM549113patient 057, normal, homogenized [OPG study]10.996
GSM549132patient 031, cancer, homogenized [OPG study]10.282895
GSM549137patient 038, cancer, homogenized [OPG study]9.2899891
GSM549142patient 047, cancer, homogenized [OPG study]7.7369281
GSM549100patient 110, normal, homogenized [OPG study]10.525496
GSM549107patient 135, normal, homogenized [OPG study]10.456995
GSM549115patient 068, normal, homogenized [OPG study]11.410597
GSM549116patient 072, normal, homogenized [OPG study]10.64396
GSM549120patient 078, normal, homogenized [OPG study]10.458395
GSM549131patient 030, cancer, homogenized [OPG study]10.234395
GSM549118patient 074, normal, homogenized [OPG study]10.040494
GSM549129patient 027, cancer, homogenized [OPG study]9.2773391
GSM549123patient 088, normal, homogenized [OPG study]10.389195
GSM549124patient 006, cancer, homogenized [OPG study]10.007595
GSM549126patient 015, cancer, homogenized [OPG study]9.9838394
GSM549128patient 025, cancer, homogenized [OPG study]8.9945689
GSM549103patient 117, normal, homogenized [OPG study]10.177595
GSM549117patient 073, normal, homogenized [OPG study]11.289197
GSM549138patient 041, cancer, homogenized [OPG study]10.445496
GSM549141patient 045, cancer, homogenized [OPG study]10.46496
GSM549130patient 028, cancer, homogenized [OPG study]9.7001993
GSM549101patient 111, normal, homogenized [OPG study]10.167595
GSM549105patient 128, normal, homogenized [OPG study]10.397496
GSM549106patient 134, normal, homogenized [OPG study]6.5086365
GSM549112patient 048, normal, homogenized [OPG study]10.885797
GSM549125patient 011, cancer, homogenized [OPG study]10.32596
GSM549127patient 024, cancer, homogenized [OPG study]8.7198687
GSM549135patient 035, cancer, homogenized [OPG study]9.646992